7.8 C
Brussels
Friday, March 29, 2024
EuropeEU launches bio-defense preparedness plan against COVID-19 variants

EU launches bio-defense preparedness plan against COVID-19 variants

DISCLAIMER: Information and opinions reproduced in the articles are the ones of those stating them and it is their own responsibility. Publication in The European Times does not automatically means endorsement of the view, but the right to express it.

DISCLAIMER TRANSLATIONS: All articles in this site are published in English. The translated versions are done through an automated process known as neural translations. If in doubt, always refer to the original article. Thank you for understanding.

Newsdesk
Newsdeskhttps://europeantimes.news
The European Times News aims to cover news that matter to increase the awareness of citizens all around geographical Europe.

                                    BRUSSELS. KAZINFORM - The European Union (EU) on Wednesday stepped up its efforts to detect and fight COVID-19 variants by bringing together various stakeholders to develop new and adapted vaccines, <a rel="nofollow noopener" href="https://www.xinhuanet.com/english/2021-02/18/c_139748689.htm" target="_blank">Xinhua </a>reports.

A new project called «HERA Incubator» will gather researchers, biotech companies, manufacturers and public authorities in the EU and globally to detect new coronavirus variants, provide incentives to develop new and adapted vaccines, speed up the approval process for these vaccines, and ensure the scaling up of manufacturing capacities.

The incubator will also serve as a blueprint for the EU’s long-term preparedness for health emergencies, the European Commission said in a statement.

«New variants of the virus are emerging fast and we must adapt our response even faster,» said European Commission President Ursula von der Leyen.

Thanks to the incubator, Europe is «tackling parallel or subsequent series of pandemics deriving from the variants,» said European Commission Vice President Margaritis Schinas, adding that it is pooling resources to ensure solidarity across the EU and the world.

The EU will spend 75 million euros (90.3 million U.S. dollars) on detecting, analyzing and assessing virus variants by supporting genomic sequencing in its member states, and a further 150 million euros on stepping up research and data exchange on variants, according to the Commission.

Mechanisms have also been devised to improve clinical trials and ramp up the production of COVID-19 vaccines.

The actions, the Commission said, are in preparation for the European Health Emergency Preparedness and Response Authority (HERA), which will be a permanent structure for risk modeling, global surveillance, technology transfers, supply chain risk mapping, flexible manufacturing, and vaccine and medicine research and development.

- Advertisement -

More from the author

- EXCLUSIVE CONTENT -spot_img
- Advertisement -
- Advertisement -
- Advertisement -spot_img
- Advertisement -

Must read

Latest articles

- Advertisement -